Lipocine (LPCN) Institutional Ownership $4.87 +0.19 (+4.06%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)CurrentInstitutional OwnershipPercentage9.11%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$135.71KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$11.50K Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LPCN Institutional Buying and Selling by Quarter Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Lipocine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024 Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480% 8/9/2024 Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222% 1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275% 10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353% 7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563% 6/5/2023 EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288% Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855% 2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084% 2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332% 2/2/2023 Bailard Inc.82,957$32K0.0%N/A0.094% 11/7/2022 Virtu Financial LLC93,411$42K0.0%N/A0.106% 8/3/2022 Carson Advisory Inc.52,000$42K0.0%N/A0.059% 7/27/2022 Bailard Inc.74,400$60K0.0%N/A0.084% 7/22/2022Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164% 5/13/2022 EAM Investors LLC657,804$901K0.2%N/A0.743% 5/10/2022Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133% 4/26/2022 Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347% 2/14/2022 GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499% 2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687% 11/15/2021 GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357% 11/10/2021 Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355% 11/9/2021 Barclays PLC24,075$26K0.0%+243.3%0.027% 10/19/2021 Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282% 8/16/2021 State Street Corp304,617$426K0.0%+2,356.6%0.345% 8/13/2021 Northern Trust Corp173,117$242K0.0%+16.8%0.196% 8/13/2021 LPL Financial LLC62,750$88K0.0%+46.8%0.071% 8/13/2021 Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861% 8/13/2021 Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321% 8/12/2021 XTX Topco Ltd20,706$29K0.0%-30.8%0.023% 8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125% 8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792% 8/10/2021 Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332% 8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023% 8/5/2021 GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160% 5/19/2021 Virtu Financial LLC191,387$289K0.0%-8.0%0.217% 5/19/2021 Squarepoint Ops LLC84,001$127K0.0%+515.5%0.095% 5/18/2021 Cubist Systematic Strategies LLC55,200$83K0.0%N/A0.063% 5/18/2021 Jane Street Group LLC29,060$44K0.0%N/A0.033% 5/17/2021 Price T Rowe Associates Inc. MD89,264$135K0.0%N/A0.101% 5/17/2021 Ameriprise Financial Inc.702,000$1.06M0.0%-4.2%0.795% Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem5/14/2021 MML Investors Services LLC41,000$62K0.0%N/A0.046% 5/14/2021 XTX Topco Ltd29,929$45K0.0%N/A0.034% 5/13/2021 Barclays PLC21,594$33K0.0%N/A0.024% 5/12/2021 Northern Trust Corp148,222$224K0.0%+19.3%0.168% 5/12/2021 Geode Capital Management LLC603,713$911K0.0%+33.9%0.684% 5/11/2021 Mercer Global Advisors Inc. ADV211,210$319K0.0%-27.5%0.239% 5/10/2021 GSA Capital Partners LLP125,993$190K0.0%-32.3%0.143% 2/24/2021 Virtu Financial LLC207,996$283K0.0%N/A0.253% 2/12/2021 Mercer Global Advisors Inc. ADV291,210$396K0.0%+20.7%0.355% 2/11/2021 Northern Trust Corp124,210$169K0.0%+40.4%0.151% 2/9/2021 Bank of New York Mellon Corp60,886$83K0.0%N/A0.074% 2/5/2021BlackRock Inc.1,618,913$2.20M0.0%+0.5%1.972% 2/4/2021 GSA Capital Partners LLP185,992$253K0.0%+133.0%0.227% 1/20/2021 Kestra Advisory Services LLC346,118$453K0.0%N/A0.527% 12/10/2020 Mercer Global Advisors Inc. ADV241,210$340K0.0%-11.3%0.367% 11/6/2020BlackRock Inc.1,610,701$2.27M0.0%+122.7%2.452% (Data available from 1/1/2016 forward) LPCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LPCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: EP Wealth Advisors LLC ($13.40M), Renaissance Technologies LLC ($212K), Dimensional Fund Advisors LP ($98K), Wealth Effects LLC ($41K), and Bailard Inc. ($32K), Wealthspan Partners LLC ($29K).Learn more on LPCN's institutional investors. What percentage of Lipocine stock is owned by institutional investors? 9.11% of Lipocine stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings. Which institutional investors have been buying Lipocine stock? The following institutional investors have purchased Lipocine stock in the last 24 months: Bailard Inc. ($82.96K), Wealthspan Partners LLC ($73.95K), EP Wealth Advisors LLC ($66.98K), Dimensional Fund Advisors LP ($11.87K), and Renaissance Technologies LLC ($4.60K). How much institutional buying is happening at Lipocine? Institutional investors have bought a total of 240,360 shares in the last 24 months. This purchase volume represents approximately $1.56M in transactions. Which Lipocine major shareholders have been selling company stock? The following institutional investors have sold Lipocine stock in the last 24 months: Wealth Effects LLC ($1.20M). How much institutional selling is happening at Lipocine? Institutional investors have sold a total of 1,201,195 shares in the last 24 months. This volume of shares sold represents approximately $6.24M in transactions. Related Companies DERM Major Shareholders ANRO Major Shareholders IMUX Major Shareholders SKYE Major Shareholders MNOV Major Shareholders CNTX Major Shareholders AVTX Major Shareholders PYXS Major Shareholders IPSC Major Shareholders CLLS Major Shareholders This page (NASDAQ:LPCN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
